Status:
COMPLETED
Mirror Aided Cross Education in Post Stroke Upper Limb Rehabilitation.
Lead Sponsor:
Institute of Technology, Sligo
Collaborating Sponsors:
Sligo General Hospital
Conditions:
Stroke
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
This is a pilot randomised controlled trial investigating a combination of mirror therapy and cross-education training compared to mirror therapy alone for the rehabilitation of upper limb impairment ...
Detailed Description
The study will require participants with chronic stroke to perform an upper limb Home Exercise Program (HEP) in their own home. INTERVENTION: Experimental Group Experimental participants will perfor...
Eligibility Criteria
Inclusion
- Clinical diagnosis of ischemic or hemorrhagic stroke as determined by a stroke neurologist. Stroke will be defined as an acute event of cerebrovascular origin causing focal or global neurologic dysfunction lasting more than 24 hours diagnosed by a neurologist/gerontologist, and confirmed by computed tomography or magnetic resonance imaging.
- ≥3 months post stroke; with no restrictions on how long post stroke.
- Discharged from formal physiotherapy rehabilitation services.
- Unilateral upper limb weakness with a Medical Research Council (MRC) Scale for Strength score greater than 2 (i.e., movement with influence of gravity removed) in the limb to be assessed and treated.
- Functional active range of movement and power in non-hemiparetic side.
- Ambulatory with or without use of a walking device. Must be able to transfer into the Biodex machine.
- Older than 18 yrs.
- Not involved in any other type of structured strength training for the duration of the study.
Exclusion
- Diagnosis of additional neurological condition (including more than one stroke) or cardiovascular disease.
- Presence of musculoskeletal conditions affecting the bones and/or soft tissues of the upper extremity.
- Impaired cognition that would affect ability to informed consent (MMSE \<21).
- Presence of aphasia or visual impairments.
- Medications affecting tone less than 3/12 prior.
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2023
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT05293951
Start Date
November 1 2022
End Date
May 1 2023
Last Update
October 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ATU Sligo
Sligo, Co Sligo, Ireland, F94KR28